# Keylika — Redefining the Standard of Care for Iron Deficiency Anemia

```yaml
url: "https://forg.to/companies/keylika"
website: "https://www.keylika.com"
industry: "Healthtech"
company_size: "1-10 employees"
headquarters: "San Francisco, USA"
is_hiring: false
open_roles: 0
verified: false
created: 2026-07-23
```

## About Keylika

Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes.  Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million

## Links

- Website: https://www.keylika.com
- Forg: https://forg.to/companies/keylika

---
Listed on [Forg](https://forg.to) — the professional network for builders

_HTML version: https://forg.to/companies/keylika_